Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

Yuki Matsuda; Taro Kishi; Nakao Iwata

doi:10.1016/j.jpsychires.2013.09.002

Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	2018-2020
ページ数	3
ジャーナル	Journal of Psychiatric Research
巻	47
号	12
DOI	https://doi.org/10.1016/j.jpsychires.2013.09.002
出版ステータス	出版済み - 12-2013
外部発表	はい

All Science Journal Classification (ASJC) codes

精神医学および精神衛生
生物学的精神医学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1016/j.jpsychires.2013.09.002

他のファイルとリンク

引用スタイル

@article{3d77c0320ea64013a6bea5e74c1e796d,

title = "Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials",

author = "Yuki Matsuda and Taro Kishi and Nakao Iwata",

year = "2013",

month = dec,

doi = "10.1016/j.jpsychires.2013.09.002",

language = "English",

volume = "47",

pages = "2018--2020",

journal = "Journal of Psychiatric Research",

issn = "0022-3956",

publisher = "Elsevier Ltd",

number = "12",

}

TY - JOUR

T1 - Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia

T2 - An updated meta-analysis of randomized placebo-controlled trials

AU - Matsuda, Yuki

AU - Kishi, Taro

AU - Iwata, Nakao

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84886102138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886102138&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2013.09.002

DO - 10.1016/j.jpsychires.2013.09.002

M3 - Letter

C2 - 24079776

AN - SCOPUS:84886102138

SN - 0022-3956

VL - 47

SP - 2018

EP - 2020

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

IS - 12

ER -